Previous close | 4.90 |
Open | 5.10 |
Bid | 4.90 |
Ask | 5.60 |
Strike | 420.00 |
Expiry date | 2024-05-17 |
Day's range | 5.00 - 6.02 |
Contract range | N/A |
Volume | |
Open interest | 363 |
CRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims that the commercial launch for the first ever CRISPR-based gene therapy is progressing well.
As you might know, Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ) just kicked off its latest quarterly results...
The S&P 500 was quiet again, but Toast led several new buys. Robinhood and Arm were big earnings movers late.